InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
1
T+90 hit rate
86%
T+90 mean return
+14.3%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Templeman Thomas, Chief Technology Officer. Officer active across 1 company, notably Centessa Pharmaceuticals plc. Cumulatively, 8 disclosures have been published. Split: 2 buys · 1 sell. Total volume traded: €16k. History available since 2 June 2021. The latest transaction was disclosed on 31 March 2023 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Declarations8 total
4,103 shares@ US$3.9023.3% of flowOrdinary SharesSEC:0001847903-23-000085:0
60,400 shares0Ordinary SharesSEC:0001847903-23-000050:0
5,382 shares@ US$4.2537.0% of flowOrdinary SharesSEC:0001847903-23-000030:0
2,921 shares@ US$3.1013.5% of flowOrdinary SharesSEC:0001847903-23-000014:0
2,003 shares@ US$4.067413.2% of flowOrdinary SharesSEC:0001847903-22-000068:0
140,000 shares0Ordinary SharesSEC:0000899243-22-025472:0
250 shares@ US$20.000.0001% mcap50.0% of flowOrdinary SharesSEC:0000899243-21-022068:0
Ideal exit: 27 Feb 2022 (T+270)
250 shares@ US$20.006.5% of flowOrdinary SharesSEC:0000899243-21-022068
Ideal exit: 27 Feb 2022 (T+270)
8 of 8 declarations
About Templeman Thomas
Thomas Templeman is the Chief Technology Officer at Centessa Pharmaceuticals plc. He is responsible for the technical direction and innovation within the company. His expertise in technology and pharmaceutical research is essential for the development of new products and solutions.
